LOWMAN, HENRY

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

FERRARA, N., DAMICO, L., SHAMS, N., LOWMAN, H., & KIM, R. (2006) · Retina

Retinal Diseases and TreatmentsAngiogenesis and VEGF in Cancer

Cited by 849

Therapeutic peptides.

Lien, S., & Lowman, H. B. (2003) · Trends in Biotechnology

Chemical Synthesis and AnalysisAdvanced Drug Delivery Systems

Cited by 209

Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5

Adams, C., Totpal, K., Lawrence, D., Marsters, S., Pitti, R., Yee, S., Ross, S., Deforge, L., Koeppen, H., Sagolla, M., et al. (2008) · Cell Death & Differentiation

Cell death mechanisms and regulationMonoclonal and Polyclonal Antibodies Research

Cited by 148